Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease

Parkinson’s disease (PD) is the second most common progressive neurodegenerative disease worldwide. However, there is no available therapy reversing the neurodegenerative process of PD. Based on the loss of dopamine or dopaminergic dysfunction in PD patients, most of the current therapies focus on s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Qi, Qin, Wang-zhi, Zhang, Ao, Ye, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471472/
https://www.ncbi.nlm.nih.gov/pubmed/32112042
http://dx.doi.org/10.1038/s41401-020-0365-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471472/
https://www.ncbi.nlm.nih.gov/pubmed/32112042
http://dx.doi.org/10.1038/s41401-020-0365-y

Ejemplares similares